KEFI Minerals: Tulu Kapi project started and financings improved – Edison Note

Minerals

Since Edison’s last note, KEFI Minerals plc (LON:KEFI) has achieved a number of key development milestones and prepared the TKGM consortium and its own balance sheet for: 1) triggering project development in January 2020 starting with government funded off-site works; 2) the full repayment and cancellation of all convertible loan facilities through a set of financings announced on 17 December 2019; and 3) receipt of all permits and internal government administrative requirements required to trigger offsite development.

It has also selected a more attractive bank loan proposal to fund capex compared to the previous bond lease proposal, closed first project equity (from the government) and started development offsite. The next milestones for Tulu Kapi are the closing of private sector project equity and starting on-site development activities. On 17 February 2020, KEFI announced the approval of the TKGM shareholders for these two steps to now proceed to the next steps of closing.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Spirax Group reports 2025 results with 5% organic revenue growth and margin progress

Spirax Group reported 2025 revenue of £1.7bn, up 5% organically and ahead of global industrial production. Adjusted operating profit rose 6%, while statutory profit declined due to restructuring costs.

Persimmon posts 2025 growth as sales and revenue rise

Persimmon increased completions, revenue and profits in 2025, with housing revenue up 16% to £3.31bn. The company expects 12,000–12,500 completions in 2026, supported by strong forward sales and improved market conditions.

Nuformix receives FDA Orphan Drug status for NXP002 IPF programme

The FDA has granted Orphan Drug Designation to tranilast lystate, the active compound in Nuformix’s NXP002 programme targeting idiopathic pulmonary fibrosis, a rare lung disease affecting fewer than 200,000 people in the United States.

James Cropper and Hexcel collaborate on recycled carbon fibre materials through ECCA

James Cropper Advanced Materials and Hexcel are working together within the European Composites Circular Alliance to develop high-value composite materials made from recycled carbon fibre.

Ilika delivers first commercial Stereax electrodes to Cirtec Medical

Ilika has completed its first revenue-generating order from Cirtec Medical, supplying commercial-grade Stereax electrodes for M300 batteries used in active implantable medical device applications.

Dekel Agri-Vision sees production pick-up and strong prices in February update

Dekel Agri-Vision reported stronger palm oil output towards the end of February and continued firm CPO prices, while cashew processing resumed full capacity as the raw cashew nut purchasing season commenced.

    Search